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Pathophysiology and Etiology of Neurogenic 
Heterotopic Ossification
Nörojenik Heterotopik Ossifikasyonda Patofizyoloji ve Etiyoloji
Summary
Neurogenic heterotopic ossification (NHO) is the formation of 
pathological bone tissue in the soft tissues around joints after 
neurological injury, where ossification is not observed normally. This
condition, frequently seen in patients with spinal cord injury (SCI) and
traumatic brain injury (TBI), can cause complications such as severe 
limitation of motion, difficulty in daily living activities, nerve 
compression and pressure ulcers. NHO etiopathogenesis was reviewed
with current literature, to enlighten the research studies planned on
treatment and the precautions to prevent it. Etiology of NHO is not
completely revealed in patients with SCI and TBI, however humoral,
neural, immunological and local factors probably play a role in the 
pathophysiology. In patients with SCI, complete lesion, immobilization,
exercise, microtrauma and proprioceptive alterations may possibly 
take a role in NHO development. The most important risk factors for
patients with TBI are: spasticity, prolongation of coma state more than
2 weeks, immobilization, fractures of long bones, limitation of range of
motion, infection, and development of autonomic disregulation. 
However, it is not known which of the factors affect the severity and the
long-term outcomes of the disease. Considering the etiopathogenesis
of NHO, it is concluded that more comprehensive studies are needed to
detect and prevent the risk factors before it develops, to determine the
type of therapeutic exercises and the suitable timing of exercises. Turk
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Özet
Nörojenik heterotopik ossifikasyon (NHO), nörolojik bir hasar sonras›
normalde kemikleflmenin görülmedi¤i eklemlerin çevresindeki yumu-
flak dokuda patolojik kemik doku oluflumudur. Omurilik yaralanmas›
(OY) ve travmatik beyin hasar› (TBH) olan hastalarda s›k gözlenen bu
durum, ciddi düzeyde hareket k›s›tl›l›¤›, günlük yaflam aktivitelerinde
güçlük, sinir bas›lar› ve bas› yaralar› gibi komplikasyonlara neden ola-
bilmektedir. NHO oluflmadan önce al›nabilecek önlemler ve tedavilere
yönelik planlanacak araflt›rmalara ›fl›k tutmas› amac›yla, NHO etiyopa-
togenezi güncel literatürün eflli¤inde gözden geçirildi. OY’li ve TBH’li
hastalarda NHO’nun etiyolojisi tam olarak bilinmemekte, ancak patofiz-
yolojisinde hümoral, nöral, immünolojik ve lokal faktörler muhtemel rol
oynamaktad›r. OY’li hastalarda, yaralanman›n komplet olmas›, immobi-
lizasyon, egzersiz, mikro-travma ve proprioseptif duyu bozuklu¤unun
NHO gelifliminde olas› rolleri bulunmaktad›r. TBH olan hastalarda ise en
önemli risk faktörleri; spastisite, koma halinin 2 haftadan uzun sürme-
si, immobilizasyon, uzun kemik k›r›klar›, eklem hareket aç›kl›¤›nda k›s›t-
l›l›k, enfeksiyon ve otonomik disregülasyon geliflimidir. Ancak hangi
faktörün hastal›¤›n ciddiyetini veya uzun dönem sonuçlar›n› etkiledi¤i
bilinmemektedir. NHO’nun etiyopatogenezi göz önüne al›narak, risk
faktörlerinin belirlenerek oluflmadan önce önlenmesi, tedavi edici eg-
zersiz tiplerinin ve uygun zamanlaman›n tespitine yönelik daha kap-
saml› çal›flmalara ihtiyaç oldu¤u sonucuna var›ld›. Türk Fiz T›p Rehab
Derg 2010;56:81-7.
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Introduction
Neurogenic heterotopic ossification (NHO) is a pathological
formation of new bone tissue in muscle and connective tissue,
where normally ossification does not occur, following a 
neurological injury (1). Heterotopic ossification (HO) occurs in
10% to 53% of patients with spinal cord injury (SCI) and in 10%
to 40% of those with traumatic brain injury (TBI), and consequently
severe joint movement restrictions develop in 18% to 35% of
patients with SCI and in 8% to 10% of those with TBI (1-5).
The pathophysiology of HO is multifactorial and complex,
and could not have been explained thoroughly for years. It is
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suggested that three circumstances, including osteogenic 
precursor cell, an inducing agent and tissues predisposing 
osteogenesis, are required for the formation of HO (6).
It is known that this complication, frequently encountered in 
patients with either SCI or TBI, requires surgical removal when it 
leads to complications such as severe movement restrictions, 
difficulty in activities of daily living, nerve compressions and 
decubitus ulcers; and that there are risks of fracture and recurrence
even after surgery. Therefore, the genesis and etiopathogenesis of
NHO were reviewed with the current literature for enlightening the
studies directed towards the prevention of its formation and the 
development of therapeutic strategies. 
Heterotopic Ossification in 
Patients with Spinal Cord Injury
HO incidence is reported to be ranged between 10% and
53% depending on the study design, diagnostic methods and
diagnostic criteria used in the studies in patients with SCI (1-3,7).
NHO occurs less in non-traumatic myelopathies (6-15%) 
compared to traumatic ones and in children (3-10%) compared
to adults (8,9). The symptoms in children are not different from
those in adults, but less evident. Spontaneous regression 
occurs more frequently in children and young adults compared
to elderly patients (9). The clinical appearance ranges from an
asymptomatic situation found on direct radiographs to severe
joint restrictions, and even ankylosis. NHO leads to restriction
in the range of joint motion (ROM) in 18% to 35% of the 
patients, whereas ankylosis may develop in 3% to 8% of the 
patients (1-3). NHO develops under the SCI level and is most 
frequently seen at hip joint (70-97%), followed by knee, elbow,
shoulder, hand and spine, in order of frequency (2,10). The 
limitation of hip ROM causes loss of adequate sitting, pressure
sores, pain and functional restrictions in activities of daily living
(11). The low neuropathy rate due to HO, despite the fact that
HO may compress adjacent vessels and nerves in the patients
with SCI, is associated with the sensory loss already existing in
complete patients (1). NHO is often diagnosed in the second
month, generally within the first 6 months after SCI; however, it
is reported that NHO may develop years after the SCI (2).
Pathophysiology
NHO originates from the connective tissue lying between
the muscles, outside of the joint capsule. The joint space and
capsule are preserved. It may be contiguous with the bones, but
does not involve the periost. Muscle fibrils are not mainly 
involved, but they may be compressed by calcified soft tissue
and local muscle necrosis may develop (1).
NHO begins as an oedematous inflammatory reaction with
an increased blood flow in the affected soft tissue area. First,
exudative cell infiltration takes place. Then, fibroblastic cell 
proliferation occurs followed by osteoid formation and finally
bone matrix development is seen. Within the first 2 weeks, 
primitive bone foci are observed as small masses in the 
fibroblastic mesenchymal reaction area, primarily in the periphery.
Osteoblasts produce tropocollagen, which is a polymerized
form of collagen and synthesize alkaline phosphatase (AP). AP
degrades pyrophosphate, which is a compound that prevents
calcium deposition. The newly developing ectopic bone matrix
inactivates nearby pyrophosphate. Therefore, AP allows 
precipitation of calcium and mineralization of bone matrix (12).
Mineralization process of soft tissue includes a gradual 
precipitation of hydroxyapatite crystals. In the maturation 
process of HO, the primitive bone is maturated by time and the
lamellar bone is formed from the periphery towards the center.
The maturation of the bone is generally completed within 6-18
months. Mature NHO mimics normal bone both radiologically
and histologically and includes Haversian canals, cortex, blood
vessels and bone marrow with a very low amount of 
hematopoiesis (1,6).
Three circumstances should be met to form HO: osteogenic
precursor cell, an inducing agent and an appropriate 
environment consisting of the tissues predisposing osteogenesis (6).
Although the mechanism of NHO has not been known exactly
yet, humoral, neural and local factors are likely to play a role in
its pathophysiology (Figure 1). There is either a migration of the
remote mesenchymal cells to the affected area and their 
transformation into osteoblasts, or a transformation of local
mesenchymal cells directly into osteoblasts. It is unknown
whether these cells migrate randomly or as a response to 
certain chemotactic factors, but it is reported that many factors
are of importance in the transformation of the mesenchymal
cells into osteoblasts (1).
Humoral Factors
In studies on sera from patients with SCI, it has been shown
that humoral mechanisms can be effective (10,13). In a study, 
investigators incubated the sera of the SCI patients with and
without HO at the 4th to 7th months after the injury and the 
sera of normal individuals with human osteoblasts in tissue 
culture, and they found an increase in osteoblast-stimulating
factor in the patients with SCI, which was more prominent in
the patients with HO (13). In the study by Renfree et al. (10) the 
sera of patients with SCI were incubated with osteoblasts of 
fetal rats 12 weeks after the event, a significant increase in 
serum mitogenic activity was observed, but no significant 
difference was found when the patients with HO were 
compared with the other patients and healthy controls. The 
results suggest that the increase in mitogenic activity may 
indirectly play a role in the process stimulating the bone 
formation.
Although humoral factors play a role in the process of 
stimulation of bone formation in patients with SCI, their 
genesis and biological features are still unknown. However, with
the experimental studies on in vitro ectopic bone formation, an
inducing protein for bone formation released by demineralized
bone tissue has been identified. This protein is called bone
morphogenetic protein (BMP) (11). These morphogenetic 
proteins play a critical role not only in HO pathogenesis, but 
also in normal embryo growth. During the growth of the 
embryo, BMPs specialize in many tissue types and play a role in
the differentiation of bony structures as well as connective 
tissue. The effectiveness of BMP in osteogenesis during the
fracture healing process has been shown (14). Another protein
group is also important in the regulation of the effects of BMPs.
These proteins are BMP receptors and BMP antagonists. 
A deficiency of these proteins will cause an increase or a 
decrease in the effects of BMPs.
Moreover, a potential bone resorption and collagen 
destruction occurred in patients with SCI may play a role in the
emergence of some osteogenesis-inducing factors not defined
yet exactly. In the NHO pathogenesis, it is proposed that 
non-collagen proteins play a role and that fibroblasts take over
the role of osteoprogenitor cells (15). 
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Neural effect on the development of NHO should be 
regarded. It is suggested that the damage of the intermediolateral
sympathetic column after SCI may lead to autonomic dysfunction
and subsequently to HO. In contrast, the continuous exposure
to neurogenic irritation is proposed as a central factor in 
situations in which some of the fibrils of the intermediolateral
tractus remained intact (6). Recently, vascular and metabolic
changes, resulted from the injury of the autonomic nervous
system, are reported to take place in the etiology of HO (1). The
dysfunction of sympathetic system causes local microvascular
changes in the affected tissues, arterio-venous shunt and 
increased vasculature, vascular stasis, oedema and prolonged
sweating (7). In a study on biopsy from paraplegic patients by
Lotta et al., alterations were determined in the endothelial cells
and in the capillary basal membrane in the cutaneous and 
subcutaneous tissues near the HO region (7). It is not known
whether these changes occur as causes for or secondary to
NHO. The hypothesis that the disruption of the neuro-
immunological pathways causes the development of NHO by
deteriorating the balance between the osteoblasts and the 
osteoclasts is still accepted. Regardless of its reason, the 
presence of interstitial oedema, whether due to a deteriorated
autonomic regulation, hypersensitivity or hypoproteinemia,
provides a suitable environment to trigger the pathological 
calcification of the bone (1).
Furthermore, the cessation of signals from the proprioceptive
receptors below the lesion level in patients with SCI leads to 
absence of detection of these signals by the somatosensory
areas placed in the anterior parietal cortex. The signals are 
interrupted in the way following the dorsal root ganglion. The
spinal cord loses its ability to control below the lesion level.
Consequently, the tissues become more vulnerable to trauma.
When there is an interruption in the neuronal network based on
the data from the receptors placed in the ligaments and 
muscles, ectopic bone formation can occur (16).
Local Factors
Local factors predisposing to NHO are venous thrombosis,
hemostasis, infection, pressure sore and microtrauma. These
factors lead to tissue damage and inflammation, and 
consequently to tissue hypoxia, and cause ectopic bone 
formation by providing a suitable environment or by adding 
humoral factors to the inflammatory process. In this instance,
the inflammatory factors such as prostaglandin-E2 (PG-E2) and
interleukin-1 (IL-1) play a role. Animal studies show that PG-E2
has angiogenic and vasodilator effects and increases the 
periosteal lamellar bone production dose-dependently along
with IL-1 (17). Additionally, it was shown that a subcutaneous 
PG-E2 injection administered to rats could lead to HO (18). In
another study, abnormalities in PG-E2 levels in 24-hour urine
samples from patients with SCI were observed (3). However, it
is difficult to interpret the PG-E2 level in the SCI patients who
have urinary tract infection or sperm discharge in urine. The
fact that these two groups constitute the majority of patients
with SCI makes difficult to understand the mechanism of action
of PG-E2.
Genetic Factors
Generally, no association between NHO and race was found.
However, higher rates in favour of young men have been
reported in some studies (1). A genetic predisposition to NHO
Figure 1. The pathophysiology of heterotopic ossification in patients with spinal cord injury. DVT: deep venous thrombosis, OAC: oral anti-coagulant
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related to the human leukocyte antigen system (HLA) is 
reported. Despite the opinion supporting an association 
between HLA-B18, HLA-B27 and NHO, there are studies 
suggesting no association (19,20).
Clinical Risk Factors
Clinical factors related to NHO are lesion level and severity,
exercises, deep venous thrombosis (DVT), spasticity, pressure
sore and urinary tract infection (UTI) (1,2,8,11,21-29).
Lesion level and severity: NHO is more frequently seen in
patients with inferior cervical or upper thoracic lesions; 
however, the completeness of the lesion seems to be more 
important than its level (11,21). Although no association 
between NHO and the severity of the motor deficit was found in
only one study (22), it has been shown in many studies that
complete SCI is more commonly associated with HO compared
with incomplete SCI (1,2). HO is less frequently encountered in
patients with lumbosacral or cauda-conus lesions, which have
high ambulation rates (21).
Exercises: The repetitive forced passive motion exercises,
performed on the joint to protect the ROM, harm the soft tissue
and initialize this pathological process. The microtraumas in the
soft tissues resulted from forced passive exercises and muscle
weakness (imbalance) create a mechanical stress at the 
muscle-tendon junction. Microtrauma leads to new bone 
formation by causing secretion of osteoblast-stimulating factor
through inflammatory response or directly (1). In a study, 
clinical HO development was defined in a group of patients in
whom passive exercises were started only seven or more days
after SCI (27). Studies performed on rabbits show that HO 
could develop by forced passive movements in paralytic 
extremities that had been immobilized for a prolonged period
(28). It is also remarkable that hip, which is the most involved
region, is the region to which the stretching exercises are 
commonly applied. The duration between SCI and the start of
passive ROM exercises is encountered to be another risk factor
for HO development (27). Silver (29) denotes that a deformati-
on in the elasticity of joint capsule, shortening in muscle length, 
adhesions in ligaments, fascia and capsule, and contracture can
be developed if passive movements are not implemented from
the day of the injury; and that initializing passive movements
after these changes increases HO risk by leading to soft tissue
damage.
DVT: The patients with traumatic SCI have the risk of 
thromboembolic events in the acute stage. Several studies
show a strong association between DVT and NHO. Colachis and
Clinchot (25) reported that the rate of association of DVT and
NHO was 5.3%, the DVT diagnosis was made before HO diagnosis
in all of the cases and HO developed on the same side where
DVT had occurred. This finding indicates that DVT is likely to be
a risk factor for HO. Perkash et al. (26) reported an increase in
coagulation parameters correlated with HO developed in 
chronic SCI patients. Furthermore, a compression of 
vascular structures by local oedema and growth of ectopic 
bone may be another mechanism by which HO may predispose
to DVT. However, the pathophysiological relationship between
DVT and NHO is not entirely defined.
Spasticity: There is a controversy about the association 
between NHO and spasticity. In some studies, it is reported that
HO is more common in SCI patients with spasticity and 
moreover, the severity of spasticity further increases the risk
(2,8). Although the observations showing that HO is more 
common in flask extremities or in those less affected from 
spasticity (23) indicate that spasticity predisposes to HO 
development, this association can be contrarily interpreted as
NHO development causes more severe spasticity (1).
Pressure sore: The damaged soft tissue region becomes
susceptible to ectopic bone formation by pressure sore and 
oedema. On the other hand, pressure sores can also be 
secondary to HO (1).
UTI: It can generate an antigenic source to start the 
immune response triggering NHO. Furthermore, bone 
demineralization accompanied by calcium loss and collagen
loss in the acute phase of SCI may increase the risks of urinary
tract stones, osteoporosis and NHO (23,24).
Heterotopic Ossification in 
Patients with Traumatic Brain Injury
NHO incidence after TBI varies from 10% to 40% (5,30,31).
NHO is less common in non-traumatic central nervous system
(CNS) pathologies compared to those which are traumatic
(1,8,32). The severity of TBI is generally correlated with HO
(30). In a study in 114 patients with severe TBI, clinical HO was
determined in only 7.9% of patients. This low rate is correlated
with the effectiveness of therapeutic programs such as 
immediate physiotherapy and botulinum toxin injections (33).
However, NHO is significantly related to morbidity, although it is
rarely seen. NHO causes pain, decrease in ROM, severe functional
restriction (8-10%) and ankylosis (5%) (30). Hence, the better
understanding of NHO etiopathogenesis will serve many 
patients.
Pathophysiology
Although the pathological mechanism underlying this 
process is not known thoroughly, it is known that an imbalance
in bone cycle occurs because of the involvement of osteoblast
differentiation. Osteocalcin has a regulatory role in osteoblast
proliferation. Typically, lower osteocalcin levels induce 
osteoblast proliferation in early proliferation stage, while 
higher osteocalcin levels prevent excessive mineralization at
the end of mineralization. In a study performed, it was reported
that lower osteocalcin levels determined in patients with TBI
could play an important role in the development of HO (34).
The bone created in post-TBI, NHO is histologically and 
radiologically similar to mature bone and is distinguished from
a simple calcification by its osteoblastic capacity. Accumulation,
proliferation and differentiation of progenitor cells occur as in
typical ossification. Subsequently, osteoprogenitor cell 
maturation and osteoblast activation occur. Development of
mature bone from soft tissue is observed. Increased vascularity
in soft tissues is the first sign to be determined. Then, collagen
fibrils are seen to be scattered among small foci of calcification
(35). Extracellular matrix is mainly composed of type 1 collagen
and is quickly mineralized after 3-4 weeks. An organized 
trabecular bone is formed after 6-12 months. If it is attained
complete maturation, development of Haversian canals, blood
vessels and medulla can be observed. There is an increased 
remodelling in heterotopic bone compared to the normal bone.
Both osteoblast and osteoclast are increased in number by
50% to 300%, compared to those in the areas of normal bone
production (30). The bone cycle in HO is shifted from a 
steady-state situation towards osteoblastic activity. Bone re-
sorption may be impaired (36).
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Humoral and Local Factors
Humoral mechanisms were shown to be responsible for the
development of NHO in TBI patients. In a study by Binder et al.
(37), it was revealed that serum obtained from patients with TBI 
augmented the effect of osteoblast-growing factor in fetal rats.
Renfree et al. (10) incubated sera of TBI patients with the 
osteoblasts of fetal rats, 12 weeks after the event. A significant
increase in serum mitogenic activity was observed, however, no
difference was seen when the patients developed NHO 
compared with the other patients and healthy controls. 
Because the results obtained did not support the presence of
humoral factor directly inducing osteoblast proliferation within
the first 12 weeks, it was claimed that the increase in mitogenic
activity could play an indirect role in the bone-inducing process.
Although “skeletal muscle stem cell” and “migrating 
osteoblastic cells” also play a role in the development of NHO,
“mesenchymal stem cells” are accepted as the principal cell
type (38). However, local environmental factors and the 
presence of osteogenic agents seem to have more priority in
the development of NHO. Microvascular alterations that reduce
the tissue oxygenation by changing the calcium content of the
skeleton and local blood flow can be responsible for the NHO
development (7). Moreover, hyperventilation used to reduce the
intracranial pressure after TBI may cause respiratory alkalosis
that predisposes to bone production. Experimentally, models
showed that an increase in pH augmented the precipitation of
calcium (30). Multiple trauma, generally accompanied by TBI,
also leads to a decrease in collagen destruction and an 
increase in bone formation (36).
Neuro-immunological Factors
As in the patients with SCI, the loss of communication 
between periphery and CNS in TBI patients leads to ectopic 
bone formation by causing autonomic disregulation, humoral
and neural changes (1,39). Hendricks et al. (39) reported that 
autonomic disregulation can increase the probability of HO 
development in patients with TBI. Moreover, as the 
proprioceptive receptors are not entirely under control, there
will be an induction of bone formation. The interruption of the
connection between joint and cerebellum or between 
somatosensory areas and posterior parietal cortex generates a
suitable environment for irregular bone formation. Passive 
forced exercises create a trauma effect because of 
misunderstanding of proprioceptive receptors. Hence, it is 
accepted that HO is also associated with the proprioceptive 
defect in patients with TBI (16). This situation can be explained
by the fact that the proteins inducing bone growth are not 
under control anymore.
Every type of pathologies that disrupts blood-brain barrier
(BBB) causes release of osteogenic factors from CNS. The 
osteogenesis-inducing character of blood obtained from TBI 
patients, which has been demonstrated in many studies, 
supported the existence of humoral osteogenic factors in these
patients. The increase in bone formation seen in NHO or
fracture healing in patients with TBI confirmed the activation
of osteogenic cells by osteogenic factors (40). In vitro evidence
showed that osteogenic factors are in the systemic circulation
(10,37,41-44). An association between callus formation and 
osteogenic factors in serum was also shown in vivo (41). Two
studies investigating the osteogenic effect of CSF after TBI 
revealed that this fluid has osteogenic effect, namely, this 
effect has central origin (42,43). However, in these studies 
human tissues were rarely used and etiologic agents could not
have been explained thoroughly (10,37,41-44).
In a study on rats, it was shown that the number of bone
marrow stromal cells (BMSC) in serum obtained 48 h after 
trauma from rats with TBI was decreased compared to control
rats. AP levels measured simultaneously were found to be 
higher than normal. These findings show the effectiveness of
humoral factors starting the maturation of osteoprogenitor
cells 2 days after trauma (43). In a similar study performed on
human serum, it was claimed that the serum of patients with
TBI had proliferative effect on fetal rat calvarial cells (FRC) (37).
In a study by Boes et al. (41), the effect of sera from 23 rats
with TBI and femur fracture on the proliferation of mesenchymal
stem cells, fibroblasts and osteoblastic cells was compared with
the effect of sera from 20 rats with only femur fracture. The 
serum of TBI group had a proliferative effect only on 
mesenchymal stem cells An association between mesenchymal
stem cell proliferation and callus formation was also shown. It
was concluded that humoral factors were effective on early HO
development and fracture healing by increasing mesenchymal
progenitors after TBI.
In a study by Eid et al. (44), it was defined that the 
post-trauma sera obtained from 10 multiple trauma patients,
seven of whom had TBI, caused a decline in human fibroblastic
and osteoblastic cell groups and in apoptosis of BMSCs, and an
increase in its proliferation 10 days after trauma. These events
induce an increase in osteogenic cell number and consequently
ossification. However, the fact that the patients evaluated in this
study had multiple traumas out of TBI leads to the fact that 
these findings cannot be correlated with TBI only.
The results of a study performed by Renfree et al. (10) do not
support the theory that sera obtained from the patients with
TBI have augmenting effects on the growth of osseous cells. In
this study, it was shown that the sera of TBI patients did not 
increase the proliferation of the calvarial cells of one-day-old
rats. No difference in osteoblast number was determined 
between the patients with or without HO.
In a study investigating the effect of CSF in NHO, CSF was
collected from four rats with TBI, 7 days after the injury. The
study showed a decline in BMSC number and an increase in AP
level in the rats exposed to CSF in both groups of TBI and 
controls. It was reported that the mineralization created by 
these two groups was greater than that seen in dexamethasone
(control) group and CSF could support ossification (43). In 
another study on human fetal osteoblasts, CSF proliferation 
rate was shown to be significantly higher in individuals with TBI
than those without TBI (42).
Numerous newer candidates have been nominated as 
centrally released humoral factors. Many factors affecting 
mesenchymal and osteoprogenitor cell proliferation have been
determined in serum after TBI, however, the results are 
controversial, and ossification and CNS damage are linked to an
accidental association (30). Interleukin-6, leptin, fibroblast-
growing factor, growth hormone, insulin-like growth factor-1,
prolactin and parathyroid hormone are the substances 
investigated and found to be ineffective (30,36,45). It can be
said that the most promising candidate is the BMP family. It was
shown that BMP could start bone formation in vivo and in vitro
in animal models (46). As shown in cases with fibrodysplasia
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ossificans progressiva, the disruption of BMP signals can cause
HO development (47). However, their effects on ossification are
controversial because of the fact that their systemic effects are
limited despite their local importance (48).
Genetic Factors
In a study by Minaire et al. (19) investigating the presence of
HLA antigens in 32 TBI patients, 23 of whom developed HO, it
was reported that HLA-B 18 was not determined in the patients
without HO. On the contrary, HLA-B 18 tissue antigen was 
determined in 25.7% of TBI patients who developed HO and in
7.6% of healthy controls. However, further studies did not 
support these findings (20).
Clinical Risk Factors
The most important risk factors defined for HO 
development in patients with TBI are spasticity, coma situation
longer than 2 weeks, immobilization, extensive axonal damage,
long bone fractures, restrictions in ROM, infection and 
development of autonomic dysfunction during follow-up
(6,31,39,49-53). However, the effects of these factors on the 
severity of the disease and long-term outcome are unknown.
Among these risk factors, only autonomic dysregulation was
defined to have a strong predictive relationship with HO 
development (39).
In a study on 86 severe TBI patients by Hurvitz et al., it was
determined that there was a significant association between
the duration of coma and HO development, but no correlation
with neuroimaging and spasticity (49). Citta-Pietrolungo et al.
(50)defined that coma, immobility and spasticity were likely to
be etiologic factors in HO development.
Spielman et al. (53), in their study, suggested that spasticity
led to HO development in patients with TBI and reported that
all of 20 TBI patients with spasticity developed HO. It has been
reported that HO is seen along with spasticity in TBI patients,
HO is regressed along with spasticity when neurological 
recovery occurs, and surgery increases the risk of relapse of
HO. In a retrospective study performed on 496 patients with
TBI, it was shown that spasticity was completely established in
all of the patients who developed HO and 89% of the joints 
developed HO located in spastic extremity (31).
It is reported in the literature that HO incidence increased if
elbow joint is also injured with TBI (51). In TBI patients with 
fractures, an excessive callus tissue is formed, but fracture 
union is delayed compared to those without TBI. Furthermore,
it has been reported that the created callus tissue was not 
normal radiologically and histologically, including HO signs (52).
There are studies which reported that systemic infection is
a probable risk factor for HO development in patients with TBI
(39). Moreover, it is reported that HO can develop in patients 
requiring mechanical ventilation because of respiratory 
distress or in patients given iatrogenic neuromuscular blockage
in intensive care units (54,55).
Conclusion
While etiology of NHO in patients with SCI and TBI is not clear
yet, humoral, neural, immunological and local factors may play
a role in the pathophysiology. Vascular stasis, oedema, 
tissue hypoxia, hypercalcemia, alterations in sympathetic 
nervous system activity, proprioceptive sensory deficit, 
prolonged immobilization and exercises after immobilization
are the factors responsible for the development of NHO. 
Furthermore, there are some distinct clinical factors 
contributing to the development of NHO in both diseases.
It is concluded that more comprehensive studies are needed
to demonstrate the effects of the individual types of therapeutic
exercise and the optimum timing in the prevention of NHO 
development in addition to detection and prevention of risk 
factors in order to contribute its therapy.
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